Real-world comparison of daratumumab-based regimens in relapsed/refractory multiple myeloma using health record data
DOI:
10.1016/j.bneo.2024.100003
Publication Date:
2024-02-15T06:16:36Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (23)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....